WO2011093675A3 - 혈액으로부터 직접 폐암 진단 및 폐암의 서브타입 진단이 가능한 마커를 선별하는 시스템 생물학적 방법 및 이로부터 선별된 혈액으로부터 직접 폐암 진단 및 폐암 서브타입 진단이 가능한 마커 - Google Patents
혈액으로부터 직접 폐암 진단 및 폐암의 서브타입 진단이 가능한 마커를 선별하는 시스템 생물학적 방법 및 이로부터 선별된 혈액으로부터 직접 폐암 진단 및 폐암 서브타입 진단이 가능한 마커 Download PDFInfo
- Publication number
- WO2011093675A3 WO2011093675A3 PCT/KR2011/000629 KR2011000629W WO2011093675A3 WO 2011093675 A3 WO2011093675 A3 WO 2011093675A3 KR 2011000629 W KR2011000629 W KR 2011000629W WO 2011093675 A3 WO2011093675 A3 WO 2011093675A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lung cancer
- marker
- blood
- subtype
- diagnosis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
- G16Z99/00—Subject matter not provided for in other main groups of this subclass
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Abstract
본 발명은 혈액으로부터 직접 폐암 및 폐암의 서브타입 진단이 가능한 마커를 선별하는 시스템 생물학적 방법 및 이에 의하여 선별된 혈액으로부터 직접 폐암 진단 및 폐암 서브타입의 진단이 가능한 마커에 관한 것이다.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020100008095A KR101378919B1 (ko) | 2010-01-28 | 2010-01-28 | 혈액으로부터 직접 폐암 진단 및 폐암의 서브타입 진단이 가능한 마커를 선별하는 시스템 생물학적 방법 및 이로부터 선별된 혈액으로부터 직접 폐암 진단 및 폐암 서브타입 진단이 가능한 마커 |
| KR10-2010-0008095 | 2010-01-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2011093675A2 WO2011093675A2 (ko) | 2011-08-04 |
| WO2011093675A3 true WO2011093675A3 (ko) | 2012-02-02 |
Family
ID=44320007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/KR2011/000629 WO2011093675A2 (ko) | 2010-01-28 | 2011-01-28 | 혈액으로부터 직접 폐암 진단 및 폐암의 서브타입 진단이 가능한 마커를 선별하는 시스템 생물학적 방법 및 이로부터 선별된 혈액으로부터 직접 폐암 진단 및 폐암 서브타입 진단이 가능한 마커 |
Country Status (2)
| Country | Link |
|---|---|
| KR (1) | KR101378919B1 (ko) |
| WO (1) | WO2011093675A2 (ko) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103336915A (zh) * | 2013-05-31 | 2013-10-02 | 中国人民解放军国防科学技术大学 | 基于质谱数据获取生物标志物的方法及装置 |
| TWI819228B (zh) * | 2013-08-05 | 2023-10-21 | 德商伊瑪提克斯生物科技有限公司 | 新穎肽類，細胞及其用於治療多種腫瘤的用途，其製造方法及包含其等之醫藥組成物（八） |
| CA3036983A1 (en) | 2016-11-21 | 2018-05-24 | Cureab Gmbh | Anti-gp73 antibodies and immunoconjugates |
| KR102216645B1 (ko) * | 2018-10-29 | 2021-02-17 | 사회복지법인 삼성생명공익재단 | 폐암의 분자 아형 결정을 위한 바이오마커 패널 및 이의 용도 |
| AU2020329191A1 (en) | 2019-08-12 | 2022-03-31 | Regeneron Pharmaceuticals, Inc. | Macrophage stimulating 1 receptor (MST1R) variants and uses thereof |
| WO2022043517A2 (en) | 2020-08-27 | 2022-03-03 | Cureab Gmbh | Anti-golph2 antibodies for macrophage and dendritic cell differentiation |
| KR102560020B1 (ko) * | 2021-04-29 | 2023-07-26 | 연세대학교 산학협력단 | 암의 진단용 조성물 |
| CN114032309A (zh) * | 2021-11-24 | 2022-02-11 | 湖州市中心医院 | Mdk基因或mdk蛋白作为生物标志物在肺癌诊断中的应用 |
| CN114878820A (zh) * | 2022-05-30 | 2022-08-09 | 湛江中心人民医院 | 肺腺癌病理诊断标志物及其应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008031169A (ja) * | 2006-07-26 | 2008-02-14 | Novartis Ag | 線維芽細胞増殖因子受容体が仲介する障害の処置法 |
| US20080182245A1 (en) * | 2004-05-28 | 2008-07-31 | David Brown | Methods and Compositions Involving MicroRNA |
-
2010
- 2010-01-28 KR KR1020100008095A patent/KR101378919B1/ko active IP Right Grant
-
2011
- 2011-01-28 WO PCT/KR2011/000629 patent/WO2011093675A2/ko active Application Filing
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080182245A1 (en) * | 2004-05-28 | 2008-07-31 | David Brown | Methods and Compositions Involving MicroRNA |
| JP2008031169A (ja) * | 2006-07-26 | 2008-02-14 | Novartis Ag | 線維芽細胞増殖因子受容体が仲介する障害の処置法 |
Non-Patent Citations (4)
| Title |
|---|
| ANDREA H. BILD ET AL.: "Oncogenic pathway signatures in human cancers as a guide to targeted therapies", NATURE, vol. 439, no. 19, 2006, pages 353 - 357, XP002460134, DOI: doi:10.1038/nature04296 * |
| ARINDAM BHATTACHARJEE ET AL.: "Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses", PNAS, vol. 98, no. 24, 2001, pages 13790 - 13795 * |
| IVER PETERSEN ET AL: "Patterns of Chromosomal Imbalances in Adenocarcinoma and Squamous Cell Carcinoma of the Lung", CANCER RESEARCH, vol. 57, 1997, pages 2331 - 2335 * |
| WEIMIN YE ET AL.: "Helicobacter pylori Infection and Gastric Atrophy: Risk of Adenocarcinoma and Squamous-Cell Carcinoma of the Esophagus and Adenocarcinoma of the Gastric Cardia", JOURNAL OF THE NATIONAL CANCER INSTITUTE, vol. 96, no. 5, 2004, pages 388 - 396 * |
Also Published As
| Publication number | Publication date |
|---|---|
| KR101378919B1 (ko) | 2014-04-14 |
| KR20110088264A (ko) | 2011-08-03 |
| WO2011093675A2 (ko) | 2011-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2011093675A3 (ko) | 혈액으로부터 직접 폐암 진단 및 폐암의 서브타입 진단이 가능한 마커를 선별하는 시스템 생물학적 방법 및 이로부터 선별된 혈액으로부터 직접 폐암 진단 및 폐암 서브타입 진단이 가능한 마커 | |
| WO2010017515A3 (en) | Breast cancer specific markers and methods of use | |
| WO2012054638A3 (en) | Nmr systems and methods for the detection of analytes | |
| IL222252A (en) | A system, device and method for detecting and diagnosing biological arrhythmias | |
| WO2015071876A3 (en) | Use of microrna markers for diagnosis of thyroid tumors and a diagnostic panel containing such markers. | |
| WO2014187959A3 (en) | Lung cancer diagnostic method and means | |
| EP3296406A3 (en) | Mirna fingerprint in the diagnosis of lung cancer | |
| WO2011015602A3 (en) | Lung cancer biomarkers | |
| WO2011107482A3 (en) | Method of diagnostic of obesity | |
| WO2011086174A3 (en) | Diagnostic gene expression platform | |
| EP4303584A3 (en) | Methods for detecting signatures of disease or conditions in bodily fluids | |
| WO2010081001A3 (en) | Recurrent gene fusions in cancer | |
| WO2011106723A3 (en) | Anti-paf antibodies | |
| EP3236262A3 (en) | Surrogate functional diagnostics test for cancer | |
| ITMI20110357A1 (it) | Sistema microfluidico per scopi di analisi e di diagnosi, nonchè corrispondente procedimento per produrre un sistema microfluidico | |
| WO2014041185A3 (en) | Colon cancer diagnostic method and means | |
| WO2013181418A3 (en) | Multiplexed diagnosis method for classical hodgkin lymphoma | |
| HK1186767A1 (zh) | 用於分析受試者血樣中疾病標記物的存在的方法 | |
| WO2009103741A3 (en) | Use of fsh receptor ligands for diagnosis and therapy of cancer | |
| WO2011146143A3 (en) | Enzymatic activity of psa as diagnostic marker for prostate cancer | |
| WO2009019370A3 (fr) | Procede de dosage de l'apolipoproteine aii pour le diagnostic in vitro du cancer colorectal | |
| HK1174955A1 (en) | Detecting pax2 for the diagnosis of breast cancer pax2 | |
| WO2009019369A3 (fr) | Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal | |
| EP4270007A3 (en) | Use of dna-transcription factor complexes for cancer detection | |
| WO2012018866A3 (en) | Methods and compositions for the diagnosis and treatment of breast cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11737314 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 11737314 Country of ref document: EP Kind code of ref document: A2 |